Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

0.5159 -0.0741 (-12.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Unicycive Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Barnes & Noble Education Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
Gainers Barnes & Noble Education, Inc. (NYSE: BNED) rose 25% to $2.15 in pre-market trading after the company posted better-than-expected quarterly sales. 
Via Benzinga
Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
Via Benzinga
BioMedNewsBreaks – Unicycive Therapeutics Inc. (NASDAQ: UNCY) Announces up to $130M to Commercialize and Launch Investigational New Drug
Via Investor Brand Network
Looking Into Unicycive Therapeutics's Recent Short Interest
Via Benzinga
Unicycive: The Company Developing Key Kidney Therapies
by\nJohnny Rice, Benzinga Contributor 
Via News Direct
Unicycive: The Company Developing Key Kidney Therapies
Doug Jermasek, Executive Vice President, Corporate Strategy for Unicycive Therapeutics, Inc. (NASDAQ: UNCY), was recently interviewed by Benzinga. 
Via TheNewswire.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dow Tumbles 250 Points Following Powell's Comments; Crude Oil Down 2%
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 250 points on Tuesday. The Dow traded down 0.77% to 33,172.39 while the NASDAQ fell 0.72% to 11,591.36. The S&P 500... 
Via Benzinga
The Unmet Need For Innovative And Effective Treatments For Kidney Disease: Acute Kidney Injury
By Julian Richard, Benzinga 
Via TheNewswire.com
The Unmet Need For Innovative And Effective Treatments For Kidney Disease: Acute Kidney Injury
The Unmet Need For Innovative And Effective Treatments For Kidney Disease: Acute Kidney Injury 
Via News Direct
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Nasdaq Rises 50 Points; Ciena Earnings Top Expectations
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Monday. The Dow traded up 0.16% to 33,444.91 while the NASDAQ rose 0.43% to 11,739.11. The S&P... 
Via Benzinga
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Dow Jumps Over 100 Points; BridgeBio Pharma Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Monday. The Dow traded up 0.42% to 33,531.77 while the NASDAQ rose 0.97% to 11,802.73. The S&P 500... 
Via Benzinga
Why Unicycive Therapeutics Stock Is Exploding Higher Monday
Unicycive Therapeutics Inc (NASDAQ: UNCY) shares are exploding higher Monday after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
The Unmet Need For Innovative And Effective Treatments For Kidney Disease: Acute Kidney Injury
Unicycive Therapeutics Inc (NASDAQ: UNCY) is a biopharmaceutical company spearheading efforts to develop effective, safe, and novel treatments for kidney disease to improve patient and caregiver... 
Via Benzinga
Amarin Posts New Data Showing Benefit of Vascepa In High-Risk Patients With Acute Coronary Syndrome
Via Benzinga
Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug Renazorb
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers
By Julian Richard, Benzinga 
Via TheNewswire.com
The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers
The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers 
Via News Direct
The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers
Unicycive Therapeutics Inc (NASDAQ: UNCY) is a biopharmaceutical company committed to developing effective and safe treatments for kidney (renal) disease to reduce death rates and improve patients and... 
Via Benzinga
Unicycive to Highlight Potential of UNI-494 to Restore Mitochondrial Function and Reduce Oxidative Stress at Two Upcoming Medical and Scientific Meetings
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
Unicycive: The Company Developing Key Kidney Therapies
Doug Jermasek, Executive Vice President, Corporate Strategy for Unicycive Therapeutics, Inc. (NASDAQ: UNCY), was recently interviewed by Benzinga. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.